Toxicity of isotretinoin in a chemoprevention trial to prevent second primary tumors following head and neck cancer

J Natl Cancer Inst. 1994 Dec 7;86(23):1799-801. doi: 10.1093/jnci/86.23.1799-a.
No abstract available

Publication types

  • Clinical Trial
  • Letter
  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Head and Neck Neoplasms / drug therapy*
  • Humans
  • Isotretinoin / adverse effects*
  • Isotretinoin / therapeutic use
  • Neoplasms, Second Primary / prevention & control*

Substances

  • Isotretinoin